Center for Health Winter Events
From networking to an exploration of mental health coverage and issues of genomic testing
The Center for Health & Pharmaceutical Law & Policy sponsored three keystone events this winter bringing together practitioners, business leaders, scholars and members of the Seton Hall Law community. Events included the following. For more information regarding these events or ideas for future programs, please contact Simone Handler-Hutchinson, Executive Director, Center for Health & Pharmaceutical Law & Policy, at email@example.com.
FDA Regulation of Genomic Testing: Will Regulation Do More Harm Than Good?
The Center for Health hosted a public lecture by Visiting Professor Barbara Evans, Professor of Law and George Butler Research Professor and Director, Center on Biotechnology & Law at the University of Houston Law Center. Professor Evans discussed whether the FDA can regulate genomic testing using the prior century’s medical device regulatory framework, why the FDA’s recent initiatives have fallen short and why Congressional action will be required if the goal of regulation is enhanced consumer safety, innovation, and the preservation of basic American values.
Insurance Coverage Issues for Mental Health and Addiction Services
The Sentinel Project, a joint project of Seton Hall Law and the Appleseed Public Interest Law Center, invited advocates and scholars to discuss the implications of providing mental health coverage under the Affordable Care Act. This day-long program included two panel discussions, “Experiences with Coverage of Mental Health and Addiction Services in New Jersey’s Individual and Small Group Markets after the Affordable Care Act" and "Identifying Pathways to Improve Care Transitions and Access to Mental Health and Addiction Services."
The program included two presentations. Michael Reisman, Assistant Attorney General, Health Care Bureau, New York State Office of the Attorney General, spoke on “Enforcement of Mental Health Parity Laws.” Joel C. Cantor, Distinguished Professor and Director, Rutgers Center for State Health Policy, presented, “Role of Behavioral Health Conditions in Avoidable Hospital Use and Cost.”
Celebrating Diversity in Compliance
Seton Hall Law and Johnson & Johnson co-hosted an evening networking event bringing together 200 healthcare compliance professionals as well as alumni practicing in, or interested in the field, and students who aspire to pursue a career in healthcare compliance. Professor Kathleen Boozang introduced the featured speakers, both leaders in healthcare compliance at Johnson & Johnson: Sujata T. Dayal, Vice President, Health Care Compliance, Pharmaceuticals; and Michael Sneed, Vice President, Global Corporate Affairs. Pictured, at left, are students with Christopher Zaleski, Vice President Global Policy & Guidance and Deidre Meehan, Asst. Gen. Counsel, Johnson & Johnson.
Pictured above, from left, are Dean Patrick E. Hobbs; Johnson & Johnson guest speakers Sujata T. Dayal, Vice President, Health Care Compliance, Pharmaceuticals and Michael Sneed, Vice President, Global Corporate Affairs; and Professor Kathleen Boozang.